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Lack of correlation between Bartonella DNA detection within fleas,
serological results, and results of blood culture in a Bartonella-infected
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Objective To correlate the presence of different Bartonella species in the blood of a stray
cat population trapped on a French military base with specific antibodies and species
detected in cat fleas.
Methods The prevalence of Bartonella bacteremia was investigated in 61 cats by plating
frozen whole blood on blood agar plates. Identification of isolates and detection of
Bartonella DNA from cat flea batches from ten cats was achieved by PCR amplification
and sequencing. Antibody detection was performed by microimmunofluorescence.
Results We obtained 38 isolates of Bartonella from blood. Sixteen were identified as B.
clarridgeiae, 15 as B. henselae genotype/serotype Houston 1 (type I), and seven as B.
henselae genotype/serotype Marseille (type II). B. henselae was detected in five fleas, and B.
clarridgeiae in one flea. Sixty-one per cent of the cats had detectable antibodies against at
least one species or serotype. Sixteen cats had antibodies against only one antigen. For
each species, the distribution of bacteremia among the cats could not be correlated with
either the distribution of infected fleas or the distribution of specific antibodies.
Conclusions The lack of correlation between Bartonella DNA detection within fleas,
serological results, and results of blood culture is probably due to a lack of natural
heterologous protection between species or serotypes. Cats suffer bacteremia with three
Bartonella species and should therefore be considered the reservoirs of at least three
human pathogens.
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I N T R O D U C T I O N
Human infections due to Bartonella species are
widely considered to be emerging diseases,
although they also include long-recognized
diseases such as Carrion’s disease due to B.
bacilliformis, trench fever due to B. quintana, and
cat-scratch disease (CSD) due to B. henselae and B.
clarridgeiae [1–3]. Newer clinical manifestations,
such as bacillary angiomatosis and peliosis hepa-
titis caused by both B. henselae and B. quintana,
chronic lymphadenopathy due to B. quintana,
and endocarditis due to B. henselae, B. quintana,
and, in one case, B. elizabethae, have been recently
identified [1,4,5]. The natural host of B. henselae and
B. clarridgeiae is the cat. The vector of B. henselae is
the cat flea, whereas the vector of B. clarridgeiae is
presently unknown, although this species has also
been detected in cat fleas [6]. Both species can be
isolated from the blood of apparently healthy cats.
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The prevalence of Bartonella spp. isolated from the
blood of cats ranges from 4% to 70%, according to
the geographic location of the survey and cat
population [7–9].
In 1996, Drancourt et al. reported a new serotype
of B. henselae named Marseille [10], which also
genotypically differed from previously character-
ized strains. The authors found that two clinical
isolates of B. henselae, from a patient with endo-
carditis and a patient with CSD, possessed slight
differences in 16S rRNA gene sequence when
compared to that of the Houston-1 type strain.
Later, by determining the 16S rRNA gene
sequence of the 18 B. henselae strains isolated in
our laboratory (unpublished data), we found that
they all belonged to one or the other of these two
different genotypes, one being B. henselae Houston
[11], and the other B. henselae Marseille [12]. Inves-
tigators in The Netherlands [13] also demonstrated
two 16S rRNA gene variants in B. henselae DNA
amplified from samples from CSD patients. This
was shown by analysis of the 16S23S rRNA gene
spacer PCR fragments and 16S rRNA gene PCR
products digested with AluI. The presence of two
genotypes was later confirmed in France [14] and
in Germany [15,16], based on sequencing of the 16S
rRNA encoding gene, the genotype Houston being
named type I and the genotype Marseille type II. In
a study reporting the prevalence of B. henselae in
bacteremic cats, the authors also reported the
presence of two different genotypes circulating
in the cat population [7,14]. Two bacteremic cats
were co-infected with the two different genotypes
[14].
Our study was performed in the context of a
control campaign for stray cats in a French military
base. Our work consisted of the determination by
blood culture and serology of the prevalence of
infection with Bartonella spp. PCR was also used to
detect Bartonella spp. in cat fleas collected from the
animals tested.
M A T E R I A L S A N D M E T H O D S
Cat sampling
The study was performed between June 1997 and
June 1999 in the context of a stray cat eradication
campaign around the canteens of a French military
base. Sixty-one cats were trapped using oral Dex-
eutanol (Instituto DEX, Seville, Spain) mixed with
fresh meat, according to the manufacturer’s
instructions. Sedated cats were then anesthetized
with Imalge`ne (Rhoˆne Me´rieux, Lyon, France),
and approximately 3 mL of blood was collected
aseptically with a syringe by intracardiac punc-
ture. A 2-mL aliquot of each sample was inocu-
lated into a serum-separating tube for serologic
analysis, and the remainder was placed in a
lithium–heparin tube for culture and frozen at
80 8C. Euthanasia of cats was performed by intra-
cardiac inoculation of Dolethal (Ve´toquinol SA,
Lure, France), according to the manufacturer’s
directions.
Isolation procedure
Frozen blood samples were thawed to room tem-
perature before plating. One milliliter of blood was
inoculated onto Columbia 5% sheep blood agar
plates (BioMerieux, Marcy l’Etoile, France). Plates
were placed in polythene bags and incubated at
37 8C in 5% CO2 (Genbag CO2 system, BioMer-
ieux). The plates were briefly held at a 458 angle to
allow the blood to flow across the agar. Plates were
initially set agar side down but were inverted after
24 h. Plates were examined weekly for evidence of
growth for up to 3 months. When Bartonella-like
colonies were observed, confirmation of their iden-
tity was achieved using the PCR-based methods
outlined below.
Identification of isolates
Presumptive identification of isolates was done by
determination of oxidase and catalase reactions
and by microscopic examination after Gram and
Gimenez staining. DNA extracts were prepared
from suspect colonies for use as templates in
PCR amplification using the QIAamp Blood Kit
(Qiagen, Hilden, Germany), according to the
manufacturer’s instructions. Molecular identifica-
tion was based on 16S rRNA gene amplification
and sequencing, as previously described [17,18].
Sequences were compared with DNA sequence
databases using the program BLAST 2.0 (The
National Center for Biotechnology and Informa-
tion).
Detection of Bartonella spp. in cat fleas
Ten batches of three to five cat fleas were obtained
from ten cats. Fleas in each batch were separately
crushed in sterile water. DNA extracts were
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prepared from crushed fleas using the QIAamp
Tissue Kit (Qiagen), according to the manufac-
turer’s instructions. Detection of Bartonella spp.
was performed using amplification and sequen-
cing of the 16S rRNA gene and intergenic spacer
region (ITS), as previously described [19].
Sequences were compared with DNA sequence
databases using the program BLAST 2.0. As a
control of PCR amplification, we used the
18Saidg18Sbi primer pair, which allows ampli-
fication of an 18S rRNA gene fragment of arthro-
pods. Consensus forward primer 18Saidg (50-
TCTGGTTGATCCTGCCAGTA-30) was deter-
mined after alignment of 18S rRNA sequences of
Drosophila melanogaster (GenBank accession num-
ber M21017) and Aedes aegypti (GenBank accession
number M95126). The consensus reverse primer
18Sbi primer was that described by DeSalle et al.
[20].
Serologic procedure
B. henselae Houston (strain Houston-1, ATCC
49882), B. henselae Marseille (strain URLLY 8,
CIP 104756) and B. clarridgeiae (strain Houston-2,
ATCC 51734) were propagated in 150-cm2 culture
flasks containing ECV 304 human endothelial cell
monolayers for use as antigens for an immuno-
fluorescence (IFA) assay. Antigens were applied
by a pen nib to each well of 30-well microscope
slides (Dynatech Laboratories Ltd, Billingshurst,
UK), air-dried, and fixed in acetone for 10 min.
Each antigen was applied at different sites in each
well to enable sera to be tested against each antigen
simultaneously. Sera were diluted 1 : 50 and 1 : 100
in phosphate-buffered saline (PBS) with 3% non-
fat dry milk and applied to the wells on the slides;
slides were incubated in a moist chamber for
30 min at 37 8C, and then subjected to three 10-
min washes in PBS. After air-drying, bound anti-
body was detected using a fluorescein isothiocya-
nate-conjugated goat anticat IgG (Jackson
Immunoresearch Laboratories, West Grove, PA,
USA) diluted 1 : 300 in PBS. Incubation, washing
and drying were performed as described above.
The slides were mounted in buffered glycerol
(Fluoprep, BioMerieux) and observed with a
Zeiss epifluorescent microscope at 400 magnifi-
cation. After this screening, serial two-fold dilu-
tions from 1 : 50 to 1 : 800 were made of positive
sera, and the antibody titers were determined as
above.
Statistical analysis
Pearson’s chi-square test was used to compare
data. A difference was considered significant
when P< 0.05.
R E S U L T S
Culture and identification
Bartonella spp. were isolated from 38 of 61 blood
samples (62%). Comparison of 16S rRNA gene
sequences of these isolates identified three differ-
ent sequences. The first sequence (16 isolates; 42%)
was identical to that of B. clarridgeiae, the second
sequence (15 isolates; 40%) was identical to that of
B. henselae Houston-1, and the third sequence
(seven isolates; 18%) was identical to that of B.
henselae Marseille.
Detection of Bartonella spp. from cat fleas
ITS amplification and sequencing led to the detec-
tion and identification of Bartonella DNA from six
of ten (60%) flea batches—B. henselae was detected
in five of these batches and B. clarridgeiae in one
(Table 1); 16S rRNA gene fragments could not be
amplified from these batches, so differentiation of
B. henselae Houston from B. henselae Marseille DNA
was not possible.
Serologic analysis
An IFA titer of 1 : 50 was considered as positive.
In total, 37 (61%) sera were positive for at least one
antigen, with titers ranging from 1 : 50 to 1 : 400.
Differences in titers between the three antigens
were easily determined, even when they differed
by only one serum dilution, because all antigens
were read simultaneously, having been spotted
into the same well on the microscope slide. Most
cat sera were reactive to the three antigens tested
Table 1 Results of B. henselae detection in fleas and blood
in the group of 10 cats from which fleas were collected
Flea detection Bacteremia Cats (n¼ 10)
– B. henselae Houston 2
– – 2
B. henselae B. clarridgeiae 1
B. henselae – 1
B. clarridgeiae – 1
B. henselae B. henselae Houston 3
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(Table 2). Nevertheless, five sera were reactive to B.
clarridgeiae only, and 11 to B. henselae only. With the
exception of one serum, for which antibodies to B.
henselae Marseille only were detected, all sera
reactive to B. henselae were reactive to both ser-
ogroups of the species. Among the 32 sera with
antibodies against B. henselae, 27 had the same
antibody titer to both serogroups, one had an
antibody titer to Houston serotype higher than
to Marseille serotype, and four had an antibody
titer to Marseille serotype higher than to Houston
serotype.
Correlation between bacteremia, detection of
Bartonella in fleas and antibody titers
Three of the four negative flea batches were
obtained from bacteremic cats. Two of the six
positive flea batches, including that from which
B. clarridgeiae DNA was amplified, were obtained
from blood-culture-negative cats. Four of the six
positive batches were obtained from bacteremic
cats. For three of these cats, the same species, B.
henselae, was isolated in blood and detected in
fleas. For one cat, B. clarridgeiae was isolated from
blood and B. henselae was detected in infesting
fleas. As three of five bacteremic cats were infested
with fleas infected with the same species as that
isolated in blood culture, and three of five blood-
culture-negative cats were also infested with Bar-
tonella-carrying fleas, we concluded that there was
no apparent correlation between the bartonella
bacteremia status of the cat and the presence of
Bartonella spp. within infesting fleas.
Among the 37 cats seropositive against Barto-
nella spp., 12 had negative blood cultures and 25
had positive blood cultures. Twenty-one of 38 cats
possessed antibodies only against the Bartonella
spp. isolated from their blood, whereas 12 of 23
non-bacteremic cats possessed antibodies which
reacted with at least one species antigen (P¼ 0.8).
Of the 22 cats which had yielded B. henselae, ten
possessed B. henselae-specific antibodies, whereas
of the 16 cats which were infected with B. clarrid-
geiae, 11 had B. clarridgeiae-specific antibodies
(P¼ 0.15). Thus, the results of blood culture were
not apparently correlated with the results of ser-
ology.
D I S C U S S I O N
In this study, more than half (62%) of the cats were
bacteremic due to Bartonella spp. This infection
rate is similar to those found in previous studies
of stray cats (Table 3), which have reported pre-
valences of 22–59% [7–9,13]. Factors which appear
to influence the prevalence of bacteremia include
cat age, presence/absence of flea infestation, and
the geographic region of the survey [6,8]. The
Bartonella spp. isolated in this study belong to three
different genotypes, namely B. clarridgeiae and the
two variants of B. henselae. No simultaneous infec-
tion with different genotypes was observed,
although this occurrence has previously been
described [6,14,21]. In our study, DNA was ampli-
fied from sweeps of at least 50 colonies with no
subsequent ambiguity in the 16S rDNA sequences,
but this approach does not preclude the possibility
of co-infection if colonies of one genotype signifi-
cantly outnumbered those of another.
This work confirms the report of Brenner et al.
[22], who demonstrated that prior freezing of
whole blood improved recovery rates of B. hense-
lae. Before implementing this procedure, the same
cat population had failed to yield any Bartonella
isolates (unpublished data). This procedure also
facilitated the isolation of B. clarridgeiae, and we
obtained 16 isolates using this approach, whereas
Heller et al. [7] were unable to isolate B. clarridgeiae
by direct blood plating. The efficacy of this proce-
dure is thought to be due to the lysis of erythro-
cytes, within which B. henselae persists [23]. That
the isolation of B. clarridgeiae was also achieved by
Table 2 Patterns of reactivity according to the antigen
tested and results of blood cultures for the 61 tested cats
Antibody detection
Blood cultures BHH BHM BC Cat (n¼ 61)
B. henselae Houston þ þ þ 6
– þ þ 1
– – þ 2
– – – 6
B. henselae Marseille – – – 3
þ þ þ 4
B. clarridgeiae þ þ þ 9
þ þ – 1
– – þ 2
– – – 4
Negative þ þ þ 1
þ þ – 10
– – þ 1
– – – 11
BHH, B. henselae Houston antigen; BHM, B. henselae
Marseille antigen; BC, B. clarridgeiae antigen.
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this procedure may also be due to the release of
this species from an intraerythrocytic location.
Although kittens and young cats have been
found to be more frequently bacteremic than older
cats [7,9,24], a lack of perinatal transmission of B.
henselae in experimentally infected cats has been
demonstrated [25]. Transmission of B. henselae
between cats has been demonstrated to occur
through cat flea contact [25,26], and as transmis-
sion by flea bite was not observed in an experi-
mental model, it is considered that B. henselae is
excreted in flea feces and enters its host via broken
skin associated with cuts or scratches [27]. Trans-
mission of B. clarridgeiae has not been previously
investigated, but the detection in this study and
the study of Bergmans et al. [21] of this species by
PCR amplification within cat fleas demonstrate
that this vector may well be involved.
Interestingly, the cat infested with B. clarridgeiae-
positive fleas was bacteremic due to B. henselae,
demonstrating that bacteremic cats can harbor
fleas infected with another Bartonella species. This
observation may be explained by the fact that after
cat fleas have fed on bacteremic cats, they excrete
viable Bartonella bacteria for up to 9 days [27,28] on
uninfected or previously infected cats.
Detectable antibodies to Bartonella spp. were
found in 61% of the cats, a prevalence similar to
those reported in other studies (3.7–81%) [8,29–31].
The antibody response to B. henselae has been
demonstrated to occur 2 weeks after infectious
challenge [32]. As cats can remain bacteremic for
up to 32 weeks [25], the presence of both bacteremia
and elevated antibody titers is a common feature.
Most cats had elevated antibodies to B. henselae and
B. clarridgeiae, although, as 16 cats had antibodies
to only one species, this pattern of dual infection
probably reflects infections by both species rather
than serologic cross-reactivity. Whether these
infections are simultaneous or successive is, how-
ever, unclear. These results are in accordance with
the study of Yamamoto et al., who demonstrated
Table 3 Results of blood culture, serology and DNA detection of Bartonella from cats in different studies, with most
remarkable data reported in each study
Procedure Species Cats (n)
Isolation
(%)
Antibodies
(%) Fleas
Most remarkable
data Ref.
LC–BP B. henselae 19 59 89.5 ND Bacteremia up to 12 months [34]
Unidentified
Bartonella
25 28 48 Increase in blood culture
and serology
positivity in cats from
CSD patients
LC-BP B. henselae
B. koehlerae
61 41 ND ND Detection of a new genotype
later named B. koehlerae [35]
Isolation of B. henselae
from fleas
[9]
LC-BP B. henselae I, II 133 22 50 7/27 (26%) Detection of B. clarridgeiae
in fleas
[21]
B. clarridgeiae Detection of two B. henselae
genotypes
LC-BP,
BCB
B. henselae I, II 94 53 ND ND Detection of two B. henselae
genotypes
[7]
B. clarridgeiae Improvement of B. clarridgeiae
by the use of blood
culture bottles
LC-BP B. henselae 205 39.5 81 ND Bacteremia associated
with young cats and a
ntibodies, especially high
titers
[8]
FHB-BP B. henselae I, II 61 62 61 6/10 (60%) Detection of two B. henselae
genotypes
This
study
B. clarridgeiae Detection of B. clarridgeiae
in fleas Lack of correlation
between bacteremia,
serology and PCR on fleas
LC, lysis–centrifugation; BCB, inoculation in blood culture bottle; FHB, frozen heparinized blood; BP, blood plating.
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lack of heterologous protection between B. clarrid-
geiae and each of the two serotypes of B. henselae
[33]. This finding, together with the fact that the two
serotypes of B. henselae are human pathogens, as is
probably B. clarridgeiae, suggests that cats could
constitute a reservoir of three different pathogens
with no cross-protection. It is not known whether
human patients with a disease caused by one type
of B. henselae can subsequently experience an infec-
tion with the other, but it is likely, as in the cat, that
there is no cross-protection. Any vaccine strategy
needs to take this problem into account.
In our study, the results of blood culture did not
correlate with Bartonella DNA detection within
fleas, as this detection occurs equally in bacteremic
and non-bacteremic cats. Furthermore, the blood-
infecting bacteria were often different from those
detected within fleas. The presence of specific
antibodies is also not correlated with bacteremia,
as seroprevalence does not differ in bacteremic
and non-bacteremic cats and is not related to the
species isolated in blood culture. Thus, results of
serology and Bartonella DNA detection in fleas are
not predictive of the presence or the identity of
infecting bacteria. The lack of correlation between
serological results, results of blood cultures and
Bartonella DNA detection within fleas also demon-
strates that possible strategies to prevent the
spread of infection among cats are to eliminate
flea infestation or to develop multivalent vaccines
that ensure protection against B. clarridgeiae and
both genotypes/serotypes of B. henselae.
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